Showing results (141-150 of 182) with videos related to
Sort By:
Pageof 19
Heart Rhythm O2|June 11, 2021
Healthcare resource utilization following ECG sensor patch screening for atrial fibrillationJill Waalen, Alison M Edwards, Anirudh Sanyal, et al.NPJ Digital Medicine|March 11, 2025
Smartphone conjunctiva photography for malaria risk stratification in asymptomatic school age childrenShaun G Hong, Sang Mok Park, Semin Kwon, et al.Journal of the American College of Cardiology|November 14, 2009
The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysisJeffrey S Berger, Deepak L Bhatt, Christopher P Cannon, et al.JACC. Cardiovascular Interventions|February 26, 2011
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary interventionFreek W A Verheugt, Steven R Steinhubl, Martial Hamon, et al.Journal of Thrombosis and Thrombolysis|September 28, 2010
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudyCharles L Campbell, Steven R Steinhubl, William C Hooper, et al.Archives of Internal Medicine|October 13, 2004
Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction studyVictor L Serebruany, Mark G Midei, Alex I Malinin, et al.Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2008
G-protein-coupled receptors as signaling targets for antiplatelet therapySusan S Smyth, Donna S Woulfe, Jeffrey I Weitz, et al.The New England Journal of Medicine|September 8, 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot, Harvey D White, Richard Gallo, et al.JACC. Cardiovascular Interventions|November 21, 2009
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trialGilles Montalescot, Richard Gallo, Harvey D White, et al.Pageof 19